5.4.3.11: phenylalanine aminomutase (D-beta-phenylalanine forming)
This is an abbreviated version!
For detailed information about phenylalanine aminomutase (D-beta-phenylalanine forming), go to the full flat file.
Word Map on EC 5.4.3.11
-
5.4.3.11
-
pantoea
-
synthesis
-
agglomerans
-
unnatural
-
taxus
-
stereochemistry
-
isomerizes
-
isomerization
-
drug development
- 5.4.3.11
- pantoea
- synthesis
- agglomerans
-
unnatural
- taxus
-
stereochemistry
-
isomerizes
-
isomerization
- drug development
Reaction
Synonyms
admH, EncP, HitA, methylidene imidazolone-dependent phenylalanine aminomutase, MIO-dependent phenylalanine ammonia lyase, PAM, PaPAM, phenylalanine 2,3-aminomutase, phenylalanine aminomutase, phenylalanine-2,3-aminomutase
ECTree
Advanced search results
Application
Application on EC 5.4.3.11 - phenylalanine aminomutase (D-beta-phenylalanine forming)
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
drug development
phenylalanine ammonia-lyases and 2,3-aminomutases are emerging as important enzymatic systems as potential target for treating diseases such as phenylketonuria and cancer
synthesis
-
the enzyme can be used for synthesis of beta-arylalanines with different groups at the benzene ring, 93% yield of 2-nitro-beta-phenylalanine. Potential prospectin application for the enzyme
synthesis
the enzyme is an attractive alternative enzymatic route to obtain enantiomerically pure alpha- and beta-amino acids, via green synthetic routes to chiral amines
synthesis
utility of the methylidene imidazolone-dependent Pantoea agglomerans phenylalanine aminomutase (PaPAM) for making non-natural beta-amino acids, substrate specificity of PaPAM with several commercially available (S)-arylalanine substrates, overview